SMMT Competitors & Alternatives
Compare Summit Therapeutics PLC with similar stocks in the same industry
Biotechnology
SMMT
Main Stock$13.05
Tradestie Score
57
Market Cap
$15.22B
Revenue Growth
-1.0%
Analyst Upside
+117.4%
Top Competitors
227 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
EXEL
Exelixis Inc
|
$55.06
|
$11.09B | 17.6 | 47 | Compare |
|
ROIV
Roivant Sciences Ltd. Common Shares
|
$33.32
|
$10.76B | - | 56 | Compare |
|
MRNA
Moderna, Inc. Common Stock
|
$55.14
|
$10.74B | - | 51 | Compare |
|
BMRN
BioMarin Pharmaceuticals Inc
|
$60.00
|
$10.53B | 43.2 | 53 | Compare |
|
IONS
Ionis Pharmaceuticals, Inc. Common Stock
|
$54.49
|
$10.49B | - | 59 | Compare |
|
BBIO
BridgeBio Pharma, Inc. Common Stock
|
$79.96
|
$10.22B | - | 56 | Compare |
|
MDGL
Madrigal Pharmaceuticals, Inc. Common Stock
|
$482.00
|
$10.01B | - | 52 | Compare |
|
TECH
Bio-Techne Corp.
|
$72.14
|
$9.33B | 103.0 | 50 | Compare |
|
CORT
Corcept Therapeutics Inc.
|
$112.80
|
$8.88B | 254.4 | 59 | Compare |
|
HALO
Halozyme Therapeutics, Inc.
|
$82.27
|
$8.77B | 29.0 | 59 | Compare |
More SMMT Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
227 stocks in this industry